|
|
 | | | |
- close
- close
- close
- close
StreetInsider.com
May 3
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/First+Bancorp.+%28FBP%29+Posts+Surprise+Q1+Loss+of+2cShare/8302490.html for the full story.
StreetInsider.com
Nov 5
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Equity+Offerings/First+Bancorp+%28FBP%29+Files+135.9M+Common%2C+1.38M+Warrant+Shelf+for+Shareholders/7846204.html for the full story.
Benzinga
Oct 24
Comment
In a report published Wednesday, Sterne Agee Group initiated coverage on First Bancorp (NYSE: FBP) with a Neutral rating and $5.00 price target.
Sterne Agee noted, “Initiating coverage of FBP with a Neutral rating. With the company reporting...
Cloud Computing
Aug 29
Comment
Libreeze Digital Library, announces a growing number of bloggers into
their recently launched Fitness Blogger Program (FBP). Fitness bloggers
who have implemented Libreeze include women focused fitness bloggers SarahLearns.com,
...
StreetInsider.com
Aug 13
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Galena+Biopharma+%28GALE%29+Gets+Japanese+Patent+for+FBP+Peptide+Variants/7652234.html for the full story.
Cloud Computing
Jul 13
Comment
From the CrossFit Games, Libreeze launches the Fitness Blogger Program
(FBP), including access to its brand new Digital Library platform.
Crossfit Endurance (crossfitendurance.com),
one of the most respected experts in the...
Marketwire
May 22
Comment
MIAMI, FL -- (Marketwire) -- 05/22/12 -- Today, FirstBank Florida announced a donation of $10,000 to March of Dimes, an organization dedicated to helping moms have full-term pregnancies and researching the problems that threaten the health of babies.
Globe Newswire
May 1
Comment
Composition of Matter patent covers FBP peptide variants for individual or expanded use in combination with the FBP vaccine, E39. Provides exclusivity until 2029, not including any patent term extensions. Patent also protects new methodology of
Benzinga
Feb 14
Comment
Galena Biopharma, Inc. (Nasdaq: GALE) today announced it has initiated its Phase 1/2 study of its Folate Binding Protein (E39) vaccine in two gynecological cancers: ovarian and endometrial adenocarcinomas. The FBP vaccine consists of the E39...
StreetInsider.com
Dec 20
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Equity+Offerings/First+Bancorp+%28FBP%29+Files+186.15M+Common+Shelf+for+Shareholders/7034669.html for the full story.
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
